XML 85 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill and Intangible Assets
9 Months Ended
Sep. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets
Goodwill and Intangible Assets
The changes in the carrying amount of goodwill for the nine months ended September 30, 2014 are as follows:
(In millions)
Generics
Segment
 
Specialty
Segment
 
Total
Balance at December 31, 2013:
 
 
 
 
 
Goodwill
$
3,991.4

 
$
734.1

 
$
4,725.5

Accumulated impairment losses

 
(385.0
)
 
(385.0
)
 
3,991.4

 
349.1

 
4,340.5

Acquisitions
13.3

 

 
13.3

Divestment
(10.5
)
 

 
(10.5
)
Foreign currency translation
(154.8
)
 

 
(154.8
)
 
$
3,839.4

 
$
349.1

 
$
4,188.5

Balance at September 30, 2014:
 
 
 
 
 
Goodwill
$
3,839.4

 
$
734.1

 
$
4,573.5

Accumulated impairment losses

 
(385.0
)
 
(385.0
)
 
$
3,839.4

 
$
349.1

 
$
4,188.5



Intangible assets consist of the following components at September 30, 2014 and December 31, 2013:
(In millions)
Weighted
Average Life
(Years)
 
Original
Cost
 
Accumulated
Amortization
 
Net Book
Value
September 30, 2014
 
 
 
 
 
 
 
Amortized intangible assets:
 
 
 
 
 
 
 
Patents and technologies
20
 
$
116.6

 
$
97.8

 
$
18.8

Product rights and licenses
10
 
3,770.1

 
2,178.0

 
1,592.1

Other (1)
8
 
166.6

 
68.6

 
98.0

 
 
 
4,053.3

 
2,344.4

 
1,708.9

In-process research and development
 
 
832.2

 

 
832.2

 
 
 
$
4,885.5

 
$
2,344.4

 
$
2,541.1

December 31, 2013
 
 
 
 
 
 
 
Amortized intangible assets:
 
 
 
 
 
 
 
Patents and technologies
20
 
$
116.6

 
$
93.8

 
$
22.8

Product rights and licenses
10
 
3,559.5

 
2,018.1

 
1,541.4

Other (1)
8
 
174.0

 
59.4

 
114.6

 
 
 
3,850.1

 
2,171.3

 
1,678.8

In-process research and development
 
 
839.1

 

 
839.1

 
 
 
$
4,689.2

 
$
2,171.3

 
$
2,517.9

____________
(1) 
Other intangible assets consist principally of customer lists and contracts.
Amortization expense, which is classified primarily within cost of sales in the Condensed Consolidated Statements of Operations, for the nine months ended September 30, 2014 and 2013, was $269.3 million and $260.6 million, respectively. Amortization expense is expected to be approximately $95 million for the remainder of 2014 and $374 million, $292 million, $248 million and $203 million for the years ended December 31, 2015 through 2018, respectively.
Indefinite-lived intangible assets, such as the Company’s IPR&D assets, are tested at least annually for impairment, but they may also be tested whenever certain impairment indicators are present. Impairment is determined to exist when the fair value is less than the carrying value of the assets being tested. During the nine months ended September 30, 2013, the Company recorded impairment charges related to IPR&D assets of $5.1 million.
During the nine months ended September 30, 2014 and 2013, approximately $6.3 million and $6.5 million, respectively, were reclassified from acquired IPR&D to product rights and licenses.